期刊文献+

^(18)F-FDG PET/CT征象及Ki-67表达与肺腺癌EGFR突变相关性研究 被引量:1

Correlation of^(18)F-FDG PET/CT Signs and Ki-67 Expression with EGFR Mutation in Lung Adenocarcinoma
在线阅读 下载PDF
导出
摘要 目的探讨^(18)F-FDG PET/CT征象及Ki-67表达与肺腺癌表皮生长因子受体(epidermal growth factor receptor,EGFR)突变的相关性。方法回顾分析95例经病理证实肺腺癌患者的^(18)F-FDG PET/CT征象、EGFR突变检测结果、Ki-67表达及一般临床资料。分析PET/CT征象(包括毛刺征、分叶征、胸膜牵拉征、血管集束征、空泡征、支气管截断征、SUVmax)、Ki-67表达、性别、年龄、吸烟史与EGFR突变状态的相关性。采用受试者工作特征(receiver operating characteristic,ROC)曲线计算最大标准摄取值(SUVmax)的截断值,Logistic回归分析影响EGFR突变的预测因素。结果EGFR突变患者的SUVmax值明显低于野生型患者(t=2.813,P=0.006),21号外显子突变患者的SUVmax低于野生型患者(t=3.274,P=0.002),野生型患者与19号外显子突变患者的SUV m a x差异无统计学意义(t=1.323,P=0.193),两种不同类型突变型SUVmax差异无统计学意义(t=-1.579,P=0.124)。ROC曲线分析显示,SUVmax预测EGFR突变的截断值为6.36。EGFR突变患者的Ki-67与野生型相比更易发生低表达(χ^(2)=4.867,P=0.027),21号外显子突变型患者Ki-67表达与野生型差异有统计学意义(χ^(2)=5.576,P=0.018),19号外显子突变型与野生型Ki-67表达差异无统计学意义(χ^(2)=0.328,P=0.567),两种不同类型突变型Ki-67表达差异无统计学意义(χ^(2)=1.791,P=0.181)。单因素分析结果显示,性别、吸烟、分叶征、血管集束征及SUVmax与EGFR突变有关(P<0.05),而年龄、毛刺征、胸膜牵拉征、空泡及支气管截断征与EGFR突变无关(P>0.05)。根据Logistic多因素分析的结果,性别、血管集束征和SUVmax是预测EGFR突变的独立因素(P<0.05)。结论SUVmax是预测肺腺癌EGFR突变的独立因素,在预测EGFR突变中具有一定的参考价值。 Objective To explore the correlation of^(18)F-FDG PET/CT signs and Ki-67 expression with epidermal growth factor receptor(EGFR)mutation in lung adenocarcinoma.Methods We retrospectively analyzed the^(18)F-FDG PET/CT data,immunohistochemical,the expression of Ki-67 and general clinical data of 95 patients with pathologically confirmed lung adenocarcinoma.To analyze the differences of PET/CT manifestations,the expression of Ki-67,gender,age,smoking status for EGFR mutation status.Receiver operating characteristic(ROC)curve was used to test the cult-off of maxium standard uptake(SUVmax).Logistic regression model was employed to analyze the independent predictive factors for EGFR.Results Patients with EGFR mutations had significantly lower SUVmax than wild-type EGFR patients(t=2.813,P=0.006).Further analysis found that patients with type Exon 21 of EGFR mutation had lower SUVmax than wild-type patients(t=3.274,P=0.002),but there was no statistical difference in SUVmax between type Exon 19 of EGFR mutation and wild type patients(t=1.323,P=0.193),There was no statistically significant difference between the two different types of mutant SUVmax(t=-1.579,P=0.124).ROC curve showed that the cut-off of SUVmax was 6.36.The low expression rate of Ki-67 was more common in EGFR mutant patients than in wild-type patients(χ^(2)=4.867,P=0.027),There was a statistically significant difference in the expression of Ki-67 between the exon 21 mutant and the wild type(χ^(2)=5.576,P=0.018);there was no significant difference in the expression of Ki-67 between the exon 19 mutant and wild type(χ^(2)=0.328,P=0.567).the expression of two different types of mutant Ki-67 was not statistically significant(χ^(2)=1.791,P=0.181).Univariate analysis showed that gender,smoking,lobulation sign,vessel convergence sign and SUVmax were all associated with EGFR mutation(P<0.05),age,spiculation sign,pleural indentation sign,vacuole sign,and bronchial truncation sign are not related to EGFR mutation(P>0.05).Logistic multivariate analysis showed that smoking status and SUVmax were the independent factors for predicting EFGR(P<0.05).Conclusion SUVmax of^(18)F-FDG PET/CT is an independent factor for predicting EGFR mutation in patients with unresectable lung adeocarcinoma,and it has certainly reference value for predicting EGFR mutation.
作者 郭丽娟 张会杰 段慧玲 李凤娟 孙凤霞 GUO Li-juan;ZHANG Hui-jie;DUAN Hui-ling;LI Feng-juan;SUN Feng-xia(Department of Nuclear Medicine,The First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,Henan Province,China;Department of Imaging,Xinxiang Central Hospital,Xinxiang 453000,Henan Province,China)
出处 《中国CT和MRI杂志》 2024年第8期35-38,共4页 Chinese Journal of CT and MRI
关键词 ^(18)F脱氧葡萄糖正电子发射计算机断层显像 肺腺癌 表皮生长因子受体 KI-67 ^(18)F-fluorodeoxyglucose Positron Emission Tomography-computed Tomography Lung Adenocarcinoma Epidermal Growth Factor Receptor Ki-67
  • 相关文献

参考文献9

二级参考文献54

  • 1王晓琴,戴穹,杨志惠.bcl-2、Ki-67和bax蛋白在宫颈上皮内瘤变和宫颈癌中的表达及临床意义[J].中国医疗前沿(学术版),2008,3(1):27-28. 被引量:9
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1370
  • 3何振宇,李彪,胡英,管迅行.Ki67在乳腺癌组织中的表达及临床病理分析[J].中国初级卫生保健,2005,19(12):94-95. 被引量:16
  • 4王晓华,马大庆,陈卉.毛刺征在CT诊断周围型小肺癌中的价值[J].中国医学影像学杂志,2006,14(2):127-130. 被引量:55
  • 5汤兆猷.现代肿瘤学[M].第2版上海:上海医科大学出版社,2000.559-898.
  • 6Assy N , Minuk G Y.Liver regernaration methods form monitoring and their applications[J].J Hepatol , 1997, 26(9): 945-952.
  • 7Voldborg B R, Damstrup L, Spang-Thomsen M ,et al.Epidermal growth factor receptor and epidermal growth factor mutations, function and possible role in clinical trials [J].Ann Oncol, 1997, 40(4): 481-490.
  • 8Choi J H, Oh J Y, Ryu S K, et al. Detection of epidermal growth factor receptor in the serm of gastric carcinoma patients [J].Cancer, 1997,79(10) :1879-1883.
  • 9Veale D, Ashcyoft T, marsh C, et al.Epidermal growth factor receptors in non-small cell lung cancer[J].Br J Cancer,1987, 55 5): 513-516.
  • 10Dazzi H, Haleston P S, Thatcher N, et al.Expression of epidermal growth factor receptor (EGFR) in non-small cell lung cancer.Use of archival tissue and correlation of EGF-R with histology tumor size, node status and survival[J]. Br J Cancer,1989, 59(5):746-749.

共引文献48

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部